The recent discovery of the unique genome of influenza virus H17N10 in bats raises considerable doubt about the origin and evolution of influenza A viruses. It also identifies a neuraminidase (NA)-like protein, N10, that is highly divergent from the nine other well-established serotypes of influenza A NA (N1-N9). The structural elucidation and functional characterization of influenza NAs have illustrated the complexity of NA structures, thus raising a key question as to whether N10 has a special structure and function. Here the crystal structure of N10, derived from influenza virus A/little yellowshouldered bat/Guatemala/153/2009 (H17N10), was solved at a resolution of 2.20 Å. Overall, the structure of N10 was found to be similar to that of the other known influenza NA structures. In vitro enzymatic assays demonstrated that N10 lacks canonical NA activity. A detailed structural analysis revealed dramatic alterations of the conserved active site residues that are unfavorable for the binding and cleavage of terminally linked sialic acid receptors. Furthermore, an unusual 150-loop (residues 147-152) was observed to participate in the intermolecular polar interactions between adjacent N10 molecules of the N10 tetramer. Our study of influenza N10 provides insight into the structure and function of the sialidase superfamily and sheds light on the molecular mechanism of bat influenza virus infection. enzymatic activity | crystallography I nfluenza virus is one of the most common causes of human respiratory infections that result in high morbidity and mortality (1) . Among the three types of influenza virus (A, B, and C), the influenza A viruses, particularly the pandemic 2009 H1N1 (pH1N1) and highly pathogenic H5N1, embody the significant threat of host switch events (2) (3) (4) (5) (6) . The recently discovered influenza virus H17N10 (only the genome was identified) from bats has the potential to reassort with human influenza viruses (7) , providing insight into the origin and evolution of influenza A viruses beyond the predominant hypothesis of waterfowls/shorebirds as the primary natural reservoir (8) . The products of the eight gene segments of H17N10 are unique among all known influenza A viruses at the primary sequence level, however. Thus, the current lack of structural and functional characterization impedes our understanding of the biology of this unusual viral genome.
Before the discovery of the bat-derived influenza virus genome, the nine serotypes of influenza A virus neuraminidase (NA) could be classified into two groups according to their primary sequence: group 1, comprising N1, N4, N5, and N8, and group 2, comprising N2, N3, N6, N7, and N9 (9) . Extensive structural and functional studies of group 2 influenza NAs have led to the development of NA as the most successful drug target against flu to date (10) (11) (12) (13) (14) (15) (16) . The recent identification of group 1 NA structures, including H5N1 NA (17) , pandemic 2009 H1N1 NA (09N1) (18) , 1918 H1N1 NA (18N1) (19) , N4 (17) , N5 (20) , and N8 (17) , further illustrates the complexity of influenza NA structures and offers some ideas for the design of next-generation NA inhibitors (21, 22) . However, the identification of N10 revealed an NA-like protein that is significantly divergent from other influenza NAs (7) , and thus whether N10 has special structural and/or functional features remains unknown.
Here we report the crystal structure of the bat-derived influenza virus N10. Our findings demonstrate that N10 has a canonical sialidase fold but lacks sialidase activity. The dramatic changes in the conserved active site residues relative to canonical influenza NAs account for both unfavorable binding and cleavage of the sialidase substrate. Moreover, a unique 150-loop (residues 147-152) is directly involved in the intermolecular interaction of monomers in the N10 tetramer.
Results
Overall Structure. The ectodomain of N10 from influenza virus A/ little yellow-shouldered bat/Guatemala/153/2009 (H17N10) was cloned and expressed using a baculovirus expression system based on a previously reported method (18, 19, 23) with slight modifications. The crystal structure of N10 was solved at a resolution of 2.20 Å and exhibited an overall structure similar to that of canonical influenza virus NAs. N10 subunits were assembled into a box-shaped tetramer, with each monomer containing a propeller-like arrangement of six-bladed β sheets ( Fig. 1A) . Comprehensive structural alignment among N10, influenza B NAs (with NA from influenza B Beijing/1/87 as the representative), and all available canonical influenza A NA subtypes revealed rmsds for Cα atoms of one N10 monomer relative to the other NAs ranging from 1.463 to 2.757 Å (Table S1 ). The average rmsd was much higher than that between two canonical influenza A NAs (<1 Å), but only moderately higher than that between canonical influenza A NAs and influenza B NA. N10 is most structurally similar to N1, particularly 09N1, and least related to influenza B NA (Table S1 ). Therefore, the structural alignment is consistent with the recent phylogenetic analysis indicating that N10 is divergent from all other influenza NAs (7) .
Unexpectedly, N10 was found to not contain four antiparallel β strands in each blade. As illustrated by superimposition with the N2 structure from A/Tokyo/3/67 (H2N2) virus (PDB ID code 1NN2), N10 lacks a β strand in blade 6, which is buried in the protein core, and instead contains a loop structure ( Fig. 1B) . Two additional unique NA structural features were also found by comparison with available influenza NA structures (excluding the drug escape mutants); N9 derived from tern [Protein Data Bank (PDB) ID code 7NN9] has only three β strands in blade 6, whereas the duck influenza N6 (PDB ID code 1V0Z) lacks one β strand in both blade 4 and blade 6.
A detailed structural analysis confirmed the presence in N10 of the highly conserved N-glycosylation site N146 (N2 numbering is used throughout the text according to the sequence alignment shown in Fig. S1 ) shared by all known influenza A NA structures. Interestingly, two sites, N259 and N269, were also identified in blade 4 of N10. The N-linked glycans of N259 are located at the bottom of the N10 head and protrude toward the virion membrane, whereas in N269, the glycans are near the top of the head and point away from the center of the putative enzymatic active site (Fig. 1C ). Regarding the calcium-binding site, each N10 monomer has the conserved high-affinity site important for stability in all known NAs (19) . This site in N10 is formed with slight differences from other NA structures, in which the calcium ion is coordinated by the main chain carbonyl oxygens of N293, D297, G345, and G347; the carbonyl group of the D324 side chain; and a water molecule ( Fig. 1D ).
Lack of Sialidase Activity. Influenza A virus NAs can be grouped based on their primary sequences (group 1 and group 2) and featured by variant structural properties (open or closed state) of the 150-loop (24) . As demonstrated by an in vitro fluorescence-based activity assay, typical group 2 N2, atypical group 1 09N1, and typical group 1 N5 displayed high sialidase activity and similar K m values (20.3-36.1 μM) as reported previously (25, 26) . In contrast, N10 exhibited no NA activity at a concentration of 1 μM using the standard NA substrate methylumbelliferyl-N-acetylneuraminic acid (MUNANA) ( Fig. 2 ). Even at a concentration of 10 μM, no N10 activity was detected, demonstrating that N10 lacks sialidase activity and may have an unknown function distinct from canonical influenza NAs.
Alterations of Conserved NA Active Site Architecture. We next investigated the structural basis for the inability of N10 to bind and hydrolyze the sialidase substrate with a terminally linked sialic acid. As illustrated in Figs. 1E and 3 by the N2-Neu5Ac complex (PDB ID code 2BAT), a classical reference structure, the charged pocket accommodating sialic acid in typical influenza A NA, can be divided into two distinct regions. First, there is an important "edge" region consisting of a positively charged arginine triad (R118, R292, and R371), as well as R152 and R224. The arginine triad forms critical high-energy salt bridges with the negatively charged C1 carboxylate of sialic acid, whereas R152 forms a hydrogen bond with the sialic acid N-acetyl group. Second, there is a negatively charged "platform" region composed of E119, E227, E276, and E277, located below the bound sialic acid. E119 and E276 form hydrogen bonds to noncharged portions of the sialic acid, and E276 is thought to play an important role in the catalytic mechanism via interaction with Tyr406 (27) . All of these residues, including influenza B, are highly conserved in N1-N9. In contrast, N10 lacks the conserved arginine triad responsible for binding of the sialic acid carboxylate group (Fig. 1F ), and the corresponding negatively charged platform region is replaced by a positively charged region in the N10 structure. Why the platform region is negatively charged rather than positively charged or neutral remains unclear, and should be addressed in the near future.
In addition, N10 has a more open pseudoactive site cavity, conferring a lower capability, if any, to tightly bind sialic acid ( Fig.  1 E and F) . More specifically, the key catalytic site residues and the framework residues responsible for stabilizing the active site are highly conserved (with the exception of D/N for residue 198) among N1-N9, as well as influenza B virus NA, but is highly divergent in N10 (Fig. 3A) . Surprisingly, N10 contains only three of the eight canonical influenza NA catalytic site residues. The salt bridge between R224 and E276 is maintained in N10. The conformation of E276 is nearly the same as that observed in the NAoseltamivir complex structures and might be sufficiently flexible to hydrogen-bond with the glycerol group of sialic acid, as reported previously (11, 16) . R118 is shifted by 1.20 Å (Cα atom), and the position of its side chain is oriented toward the bottom of the pseudoactive site. Furthermore, residue 371 is found 2.35 Å (Cα atom) away from the center of the referenced NA active site, and both residues 292 and 371 are replaced with shorter polar residues, T and Q, respectively. In addition, residues 151 and 152 are shifted even further away from the pseudoactive site (11.72 and 11.63 Å, respectively, in terms of Cα atoms compared with the N2-Neu5Ac complex). These alterations lead to the loss of the crucial interactions essential for the recognition of the sialidase substrate. Most importantly, the proposed key nucleophilic residue Y406 is replaced by a positively charged R406 in N10 (27) , which is unlikely to function in a similar manner, especially with its side chain oriented in the opposite direction relative to the canonical Y406 (Fig. 3B) . The deficiency of a key catalytic residue further supports the idea that N10 is not a canonical sialidase.
As stated earlier, only 3 of the 11 framework residues of canonical influenza NAs could be identified in N10. The conformations of both E425 and S179 in N10 resemble those in the N2-Neu5Ac complex; however, the conserved E119, E227, W178, and I222 residues, which also form contacts with sialic acid, are replaced in N10 by R119, N227, R178, and P222, respectively. This both further weakens the sialic acid-binding capability of N10 and greatly contributes to replacement of the highly conserved acidic pocket with a predominantly basic site in N10. Further analysis of the remaining five residues revealed an interesting pattern in which framework residues are altered in coordination with the substitution of key catalytic site residues. In the canonical N2-Neu5Ac complex, E277, N294, H274, and D198 help stabilize the conformation of Y406, R292, E276, and R152, respectively, and R156 is important for stabilizing the conformation of E119 and the 150loop. Nevertheless, the N10 D198 is shifted 3.6 Å (Cα atom) outward from the center compared with D198 in the N2-Neu5Ac complex. Moreover, the remaining four residues are replaced by Y277, L294, N274, and E156, resulting in significantly different chemical properties (Fig. 3C) . Overall, the effects caused by these alterations explain why N10 has a unique pseudoactive site architecture.
Special Features of the 150-Loop. Numerous studies have confirmed that the 150-loop is one of the most flexible parts of the influenza NA structure (28) (29) (30) , and there are striking structural differences among variant influenza NA subtypes at this site (17, 18, 20) . No 150-cavity in N10 could be identified compared with the uncomplexed typical group 1 VN04N1 (NA from Vietnam 2004 H5N1; PDB ID code 2HTY) and typical group 2 N2 structures ( Fig. 4 A-C) .
Detailed comparison of these three structures revealed an abnormally extended conformation of the N10 150-loop, which is located far beyond the VN04N1 active site. The 430-loop of N10 is also moved outward relative to the center of the referenced active sites so as to maintain coordination with the 150-loop, in accordance with other known NAs (18, 28) . Compared with the van der Waals interaction between P431 and I149 in 09N1 (PDB ID code 3NSS), L144 forms a more stable hydrophobic interaction with L433 in N10 (Fig. 4D) .
In view of a tetrameric N10, the 150-loop of each monomer is positioned much closer to the respective neighboring monomer compared with that in other influenza NAs (Fig. 4E) . Interestingly, it is directly involved in the intermolecular interaction at the interface of two NA monomers, which has not been reported previously. There are strong polar contacts between the 150-loop of one N10 molecule and the 100-loop (residues 105-109) of the other. In particular, the S151 main chain nitrogen hydrogen-bonds with the P105 carbonyl, and the N146 carbonyl group forms a hydrogen bond with the E109 peptide bond nitrogen. In addition, two water molecules mediate the interaction of the S151 side chain hydroxyl group with the G107 carbonyl oxygen, whereas the E109 side chain exhibits an extended state to hydrogen-bond with the N146 peptide-bound nitrogen (Fig. 4F) . We also noted the consistent presence of a helix in place of the N10 100-loop in all other active influenza NA structures. The unique secondary structure of the N10 100-loop may be attributed primarily to the presence of two proline residues at positions 105 and 108.
Discussion
The bat-derived influenza virus genome N10 protein reported here has been confirmed to have a canonical influenza NA fold. Based on previous sequence analyses (7) and our structural alignment, N10 is highly distinct from influenza B virus NA, as we have shown. Moreover, either the average sequence identity or average structural similarity of N10 to influenza A N1-N9 is lower than that of influenza B NA to influenza A N1-N9. This indicates that it may be inappropriate to designate this bat-derived NA-like molecule as a member of influenza A virus NAs, and that instead Detailed presentation of the polar interactions between the N10 150-loop of one monomer and the 100-loop of the other monomer. S151 forms one hydrogen bond with P105, and N146 forms two hydrogen bonds with E109. S151 also forms hydrogen bonds with G107 that are mediated by two water molecules.
N10 might be derived from another, unknown influenza type (either extinct or yet to be identified); however, further investigations are needed to elucidate its true evolutionary origin.
Our biochemical analysis further demonstrates that N10 is unable to function as a canonical sialidase. A recent study revealed that bats are hosts to major viral pathogens from the Paramyxoviridae family (31); thus, we compared the influenza virus N10 with the important attachment glycoprotein (also known as the "vestigial NA") of several key paramyxoviruses. In terms of both the sequence and overall structure, N10 differs dramatically from the measles virus hemagglutinin (MV-H) (32) , Nipah virus G protein (NiV-G) (33), and Hendra virus G protein (HeV-G) (34) (Table S2 and Fig. S2 ). These attachment proteins play pivotal roles in virus entry and do not contain a calcium-binding site. These findings, together with the presence of the conserved calcium-binding site important for the conformational stability of the canonical influenza NA (25) , suggest that N10 may have unknown activity. In this case, the three N-glycosylation sites observed might be important for the stability of N10 as a surface enzyme against proteolytic digestion, as reported previously (19) , and also might provide a mechanism through which the bat influenza virus evades host immune recognition (35) .
Our detailed structural analysis explains why N10 does not function as a sialidase. With its significantly altered key active site residues, surprisingly open pseudoactive site, and unfavorable surface electrostatic potential, N10 is poorly equipped to bind to sialic acid. Thus, our inability to obtain an N10-sialic acid complex structure from crystal soaking experiments despite great effort is reasonable. Furthermore, taking the hemagglutinin-neuramnidase balance into consideration (36) , H17 is also divergent from known HAs, and the H17N10 virus is unable to propagate in either cell cultures or chicken embryos (7) . This may further explain why N10 cannot use terminally linked sialic acid receptors (i.e., α2,3or α2,6-linked type) as its substrate, and why identifying the H17 receptor would be helpful in confirming its actual substrate. Therefore, the currently available influenza NA inhibitors are highly unlikely to be effective against the bat-derived influenza virus if it in fact is an actual pathogen.
More importantly, the unique N10 150-loop was found to participate in the intermolecular interaction between two adjacent NA molecules. The extended conformation of the N10 150-loop is stabilized by strong hydrogen bonds with the 100-loop of the neighboring molecule and may be much less flexible than other influenza NAs. These interactions may limit either the movement on inhibitor binding, as shown in typical group 1 NA crystal structures (17, 19, 20) , or the variant conformations in solution, as seen in the molecular dynamics simulations with several group 2 NAs (29, 30) . In addition, there is still the possibility that the 150loop of N10 might not be involved in catalysis, whereas the flexible 150-loop in canonical influenza NA might act as an important switch in the catalytic cycle (37) .
Taken together, the data from our successful structural and functional characterization of the bat-derived influenza virus N10 reveal an unusual influenza protein that lacks NA activity despite its canonical NA fold. Not only does the present study offer insight into the structure and function of the sialidase superfamily, it also raises further questions about how the bat influenza virus enters and is released from host cells if in fact it is an actual mammalian virus.
Materials and Methods
Cloning, Expression, and Purification of Influenza Virus NAs. The preparation procedures for recombinant 09N1, N2, and N5 were as described in our previous reports (18, 20, 24) . Recombinant N10 protein was prepared using our established baculovirus expression system. The cDNA encoding the ectodomain (residues 83-460, based on N2 numbering) of influenza A/little yellow-shouldered bat/Guatemala/153/2009(H17N10) NA-like protein N10 was cloned into the pFastBac1 baculovirus transfer vector (Invitrogen). A GP67 signal peptide was added at the N terminus to facilitate secretion of the recombinant protein, followed by a His tag, a tetramerizing sequence, and a thrombin cleavage site (18) . Recombinant pFastBac1 plasmid was used to transform DH10BacTM Escherichia coli (Invitrogen). The recombinant baculovirus was obtained following the manufacturer's protocol, and Hi5 cell suspension cultures were infected with high-titer recombinant baculovirus. After growth of the infected Hi5 suspension cultures for 2 d, centrifuged media were applied to a 5-mL HisTrap FF column (GE Healthcare), which was washed with 20 mM imidazole. Then NA was eluted using 300 mM imidazole. After dialysis and thrombin digestion (3 U/mg NA; BD Biosciences) overnight at 4°C, gel filtration chromatography was performed with a Superdex 200 10/300 GL column (GE Healthcare) with 20 mM Tris·HCl and 50 mM NaCl (pH 8.0). High-purity NA fractions were pooled and concentrated using a membrane concentrator with a molecular weight cutoff of 10 kDa (Millipore).
Enzymatic Activity Assay. The activities of purified 09N1, N2, N5, and N10 were tested using MUNANA (J&K Scientific) as a fluorogenic substrate (26) . The appropriate protein and substrate concentrations were chosen after several rounds of preliminary tests. Protein (10 μL) was mixed with 10 μL of buffer containing 33 mM MES and 4 mM CaCl 2 (pH 6.0) in each well of a 96-well plate, after which the plate was incubated at 37°C. The final concentrations were 10 nM for 09N1, 10 nM for N2, 10 nM for N5, 1 μM for N10, and 10 μM for BSA. Serial dilutions (0-500 μM) of preheated MUNANA (30 μL) were then added. The fluorescence intensity of the released product was measured every 30 s for 1 h at 37°C on a microplate reader (SpectraMax M5; Molecular Devices), with excitation and emission wavelengths of 355 nm and 460 nm, respectively. All assays were performed three or more times, and the K m and V m values for active NAs were calculated using GraphPad Prism.
Crystallization, Data Collection, and Structure Determination. N10 crystals were obtained using the sitting-drop vapor diffusion method. N10 protein [1 μL of 10 mg/mL protein in 20 mM Tris and 50 mM NaCl (pH 8.0)] was mixed with 1 μL of reservoir solution [30% (wt/vol) PEG2000 monomethyl ether (MME), 0.1 M sodium acetate (pH 4.6), and 0.2 M ammonium sulfate]. N10 crystals were cryoprotected in mother liquor with the addition of 20% (vol/vol) glycerol before being flash-cooled at 100 K. Diffraction data for N10 were collected at Shanghai Synchrotron Radiation Facility beamline BL17U. The collected intensities were indexed, integrated, corrected for absorption, and scaled and merged using HKL-2000 (38) . Data collection statistics are summarized in Table  S3 . The structure of N10 was solved by molecular replacement using Phaser (39) from the CCP4 program suite (40) , with the structure of 09N1 (PDB ID code 3NSS) as the search model. The initial model was refined by rigid body refinement using REFMAC5 (41) , and extensive model building was performed using COOT (42) . Further rounds of refinement were performed using the phenix.refine program implemented in the PHENIX package (43) with energy minimization, isotropic ADP refinement, and bulk solvent modeling. Final statistics for the N10 structure are presented in Table S3 . The stereochemical quality of the final model was assessed with PROCHECK (44) .
